For instance, complement activation may hamper the local anti-tumor immune response [73], with C5a in particular playing detrimental roles in tumor development by inducing a pro-tumorigenic microenvironment [74], contributing to metastatic sites [75], and improving tumor mobility [76]. The gene discussed is C5; the disease is neoplasm.